Come up with a name for your new list and we'll add to it:
Catabasis Pharmaceuticals raised a round of funding on December 17, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's dru…